Phyton Biotech

As a biotechnology leader with certified GMP facilities in Germany and Canada, @PhytonBiotech has a successful track record of developing and implementing innovative contract development solutions for clients around the world using PCF®.ow.ly/gx8R30nxbPv #plantcellculture

New production model for cyclopamine will use @PhytonBiotech’s innovative PCF® technology. Learn more here: phytonbiotech.com/about-pcf/ #innovation #plantcellculture

@PhytonBiotech announces exclusive partnership with PellePharm to develop renewable supply of cyclopamine, key ingredient in PellePharm’s investigational topical therapy for Gorlin Syndrome using our Plant Cell Fermentation (PCF®) technology. ow.ly/VZpS30nx4tp #biotech

PCF®, @PhytonBiotech's award-winning, environmentally responsible #biotech solution is ideally suited for the development of phytochemicals at commercial scale across the #pharma, Chinese medicine, cosmetic, agricultural and food ingredient industries ow.ly/m6mL30nwb5R

With a mission to develop and produce APIs and other high-value plant-based compounds via our proprietary “green” PCF®, @PhytonBiotech is an industry leader in plant cell culture development. Learn more about the PCF® process: ow.ly/el5330mJm8O #biotech #pharmaceutical

@PhytonBiotech has the capacity to meet more than one-third of global demand for paclitaxel and docetaxel. Learn how we use our green PCF® technology to produce high-quality, sustainably produced taxane APIs: bit.ly/2RowP9y #biotech #pharma #Paclitaxel #Docetaxel

@PhytonBiotech embarks on new challenge to develop manufacturing process for QS-21 to ensure sustainable supply of key vaccine ingredient. @Agenus_Bio R&D study, funded by @gatesfoundation, pilots @PhytonBiotech Plant Cell Fermentation (PCF®) technology. ow.ly/ReA230nbfml

Did you know @PhytonBiotech operates the world’s largest cGMP plant cell fermentation facility with more than 200,000 litres of fermentation capacity and multiple production lines from kilograms to tonnes of product volumes? Learn more: bit.ly/2BBDGGR #biotech #plantcell

Did you know @PhytonBiotech revolutionized the manufacturing process for paclitaxel (one of the world’s most important anti-cancer drugs) from plant cell cultures using PCF®? Read our case study here: ow.ly/yHNj30nmQL0

@PhytonBiotech is the leading global supplier of high-quality, sustainably-produced #paclitaxel and #docetaxel. We produce these APIs on a commercial scale using our own proprietary (PCF®) Technology. Learn more: phytonbiotech.com/apis/ #biotech #pharmaceutical

Our teams in Germany and Canada are uniquely qualified to carry out a full development program for plant-based compounds using our patented (PCF®) Technology, serving the pharmaceutical, Chinese Medicine, cosmetic, agricultural and food industries. phytonbiotech.com

It's @PhytonBiotech's last day at @jpmorgan's Health Care Conference in San Francisco. Connect with us to discuss how plant cell fermentation technology (PCF®) can support your unique project needs for high quality plant-derived actives. ow.ly/Gbhp30ndRNQ #jpmhc19

Did you know!? @PhytonBiotech is developing a new production method for QS-21 using plant cell cultures? Through R&D led by @Agenus_Bio & funded by @gatesfoundation Our PCF® technology will ensure continuous supply of the critical vaccine ingredient. ow.ly/ReA230nbfml

Today marks the start of the 37th Annual @jpmorgan Health Care Conference in San Francisco. We look forward to meeting with you and discussing how our plant cell fermentation technology can support your project needs. Learn more here: ow.ly/Gbhp30ndRNQ #conference #jpmorgan

$AGEN announces Bill & Melinda Gates Foundation invests ~$1M to develop novel technology for QS-21 #Innovations #vaccines @gatesfoundation⁩ ⁦@SueDHellmann⁩ prnewswire.com/news-releases/…

This project is the second R&D study affiliated with @gatesfoundation in which @PhytonBiotech is attempting to demonstrate that PCF® is a feasible alternative model for the consistent, large-scale, low-cost and commercial production of high-quality phytochemicals. #biotech

@PhytonBiotech embarks on new challenge to develop novel manufacturing process for QS-21. @Agenus_Bio R&D study, funded by @gatesfoundation, pilots @PhytonBiotech Plant Cell Fermentation (PCF®) technology. Read more here: ow.ly/ReA230nbfml #biotech #innovation #vaccines

Our proprietary #adjuvant QS-21 is critical in making #vaccines effective. We are excited to further innovate QS-21 production with this grant from Bill & Melinda Gates Foundation @gatesfoundation #gatesfoundation bit.ly/2TuV6vc #DYK What is a Vaccine Adjuvant?

@Agenus_Bio @gatesfoundation @PhytonBiotech is excited about the potential to truly revolutionize QS-21 production using our "green" PCF® technology platform. Read more here: ow.ly/Epfc30nbhWf

@Agenus_Bio @gatesfoundation @PhytonBiotech is delighted to partner with @Agenus_Bio to pioneer an innovative approach to developing QS-21 from plant cell cultures to ensure a continuous supply of this globally important vaccine ingredient. ow.ly/p3rZ30nbgbp

Agenus Awarded Grant from Bill & Melinda Gates Foundation @gatesfoundation to Enable QS-21 Innovations. For more details, please see full press release: investor.agenusbio.com/2019-01-03-Age… #innovation #vaccines #adjuvants #globalhealth #gatesfoundation #infectiousdiseases